Company profile

CG Oncology, Inc. insider acquisitions

Company CIK 0001991792 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
CGON · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Kalofonos IsabelKalofonos IsabelPOST LEONARD EPOST LEONARD ERossi ChristinaRossi ChristinaKalofonos Isabel · October 15, 2026 · Stock award · Employee Stock Option (right to buy)POST LEONARD E · October 15, 2026 · Exercise / conversion · Common StockRossi Christina · November 24, 2025 · Stock award · Director Stock Option (right to buy)POST LEONARD E · November 17, 2025 · Exercise / conversion · Common StockPOST LEONARD E · October 13, 2025 · Exercise / conversion · Common StockOct 13, 2025Oct 15, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 15, 2026CG Oncology, Inc.Employee Stock Option (right to buy)Kalofonos IsabelStock award
Oct 15, 2026CG Oncology, Inc.Common StockPOST LEONARD EExercise / conversion
Nov 24, 2025CG Oncology, Inc.Director Stock Option (right to buy)Rossi ChristinaStock award
Nov 17, 2025CG Oncology, Inc.Common StockPOST LEONARD EExercise / conversion
Oct 13, 2025CG Oncology, Inc.Common StockPOST LEONARD EExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

CGON · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Kalofonos IsabelChief Commercial Officer
Stock awardEmployee Stock Option (right to buy)Derivative security · Code A92,0000Value: 0Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M1,0000.6Value: 600Currency not specifiedView ↗
Trade: Stock awardDirector Stock Option (right to buy)Derivative security · Code A20,8890Value: 0Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M1,0000.6Value: 600Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M1,0000.6Value: 600Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →